X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SANOFI INDIA DR. DATSONS LABS/
SANOFI INDIA
 
P/E (TTM) x -10.9 30.0 - View Chart
P/BV x 0.2 5.3 3.1% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 DR. DATSONS LABS   SANOFI INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SANOFI INDIA
Dec-16
DR. DATSONS LABS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1264,560 2.8%   
Low Rs314,400 0.7%   
Sales per share (Unadj.) Rs133.01,028.5 12.9%  
Earnings per share (Unadj.) Rs0.2129.0 0.1%  
Cash flow per share (Unadj.) Rs6.6186.0 3.6%  
Dividends per share (Unadj.) Rs068.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs128.8753.6 17.1%  
Shares outstanding (eoy) m31.6623.03 137.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.4 13.5%   
Avg P/E ratio x516.134.7 1,485.7%  
P/CF ratio (eoy) x11.824.1 49.2%  
Price / Book Value ratio x0.65.9 10.2%  
Dividend payout %052.7 0.0%   
Avg Mkt Cap Rs m2,477103,174 2.4%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m563,592 1.6%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m4,21123,686 17.8%  
Other income Rs m79708 11.1%   
Total revenues Rs m4,28924,394 17.6%   
Gross profit Rs m5695,281 10.8%  
Depreciation Rs m2041,313 15.6%   
Interest Rs m43015 2,868.0%   
Profit before tax Rs m134,661 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,691 0.4%   
Profit after tax Rs m52,970 0.2%  
Gross profit margin %13.522.3 60.6%  
Effective tax rate %48.036.3 132.4%   
Net profit margin %0.112.5 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,85215,673 43.7%   
Current liabilities Rs m6,7116,678 100.5%   
Net working cap to sales %3.338.0 8.8%  
Current ratio x1.02.3 43.5%  
Inventory Days Days16176 211.7%  
Debtors Days Days31822 1,427.3%  
Net fixed assets Rs m3,6738,098 45.4%   
Share capital Rs m317230 137.5%   
"Free" reserves Rs m3,76117,088 22.0%   
Net worth Rs m4,07817,356 23.5%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63325,400 49.7%  
Interest coverage x1.0311.7 0.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.9 35.7%   
Return on assets %3.411.8 29.3%  
Return on equity %0.117.1 0.7%  
Return on capital %7.726.9 28.5%  
Exports to sales %22.924.5 93.5%   
Imports to sales %14.328.0 51.1%   
Exports (fob) Rs m9645,801 16.6%   
Imports (cif) Rs m6026,627 9.1%   
Fx inflow Rs m9647,145 13.5%   
Fx outflow Rs m6076,846 8.9%   
Net fx Rs m357299 119.4%   
CASH FLOW
From Operations Rs m1,3453,226 41.7%  
From Investments Rs m-2,256-1,555 145.1%  
From Financial Activity Rs m-1,200-1,818 66.0%  
Net Cashflow Rs m-2,111-147 1,435.9%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.0 14.4 -  
FIIs % 1.4 14.6 9.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.5 896.2%  
Shareholders   20,807 15,184 137.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - WOCKHARDT LTD. COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS